Table 5.
Treatment-emergent adverse event (TEAE) profiles after co-administration of candesartan and amlodipine and after administration of each drug alone in healthy subjects
| Symptom and sign | Combination (n=20) | Alone (n=20) |
|---|---|---|
| Part 1 (candesartan) | ||
| Blood pressure diastolic decreased | 3 (3) | 2 (2) |
| Dizziness postural | 1 (1) | 2 (2) |
| Headache | 2 (2) | – |
| Somnolence | 2 (2) | – |
| Part 2 (amlodipine) | ||
| Palpitations | 1 (1) | 1 (1) |
| Blood pressure diastolic decreased | 6 (6) | – |
| Headache | 1 (1) | 4 (4) |
| Rhinorrhoea | – | 2 (2) |
Note: TEAEs that were reported at least twice are presented as number of subjects (number of events).